Sugammadex doses for effective dose - reaction comparative study for the reversal of neuromuscular blockade induced by rocuronium.

Sugammadex doses for effective dose - reaction comparative study for the reversal of neuromuscular blockade induced by rocuronium. - Sugammadex doses for effective dose - reaction comparative study for the reversal of neuromuscular blockade induced by rocuronium.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025218

Enrollment

Registered

2016-12-10

Start date

2016-09-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients scheduled for elective surgery requiring general anesthesia

Interventions

sugammadex are administered

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients scheduled for elective surgery requiring general anesthesia the patients were ASA physical status 1-3

Exclusion criteria

Exclusion criteria: the patients were ASA physical status 4-6 the patients who have renal or neuromuscular disorders the patients who are scheduled hepatic or renal surgery

Design outcomes

Primary

Measure	Time frame
The 95% effective dose of Sugammadex	—

Countries

Japan

Contacts

Public ContactOSAMU KITAJIMA

Nihon University School of Medicine Department of Anesthesiology

kitajima.osamu@nihon-u.ac.jp81339728111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026